FDA Commissioner McClellan Sworn-In; First Focus Is Employee Morale
Executive Summary
FDA Commissioner Mark McClellan, MD/PhD, is beginning his tenure at the agency by emphasizing employee morale and retention
You may also be interested in...
FDA Cardio-Renal Head Throckmorton Moves Up To Acting Deputy Of CDER
FDA Cardio-Renal Drug Products Division Director Douglas Throckmorton, MD, is moving up to the position of acting deputy director of CDER, effective May 3
FDA Cardio-Renal Head Throckmorton Moves Up To Acting Deputy Of CDER
FDA Cardio-Renal Drug Products Division Director Douglas Throckmorton, MD, is moving up to the position of acting deputy director of CDER, effective May 3
FDA “Strategic Plan” Team Takes Shape: McClellan Names Senior Advisors
FDA Senior Economic Advisor Tomas Philipson, PhD, will work with Commissioner Mark McClellan, MD/PhD, to develop strategic initiatives